Magnetically modified-mitoxantrone mesoporous organosilica drugs: an emergent multimodal nanochemotherapy for breast cancer

Magnetically modified-mitoxantrone mesoporous organosilica drugs: an emergent multimodal nanochemotherapy for breast cancer

Abstract Background Chemotherapy, the mainstay treatment for metastatic cancer, presents serious side effects due to off-target exposure. In addition to the negative impact on patients’ quality of life, side effects limit the dose that can be administered and thus the efficacy of the drug. Encapsula...

Full description

Bibliographic Details
Main Authors: Eva Romaní -Cubells, Samuel Martínez-Erro, Victoria Morales, Ana Chocarro-Calvo, José M. García-Martínez, Raúl Sanz, Custodia García-Jiménez, Rafael A. García-Muñoz
Format: Article
Language:English
Published: BMC 2024-05-01
Series:Journal of Nanobiotechnology
Subjects:
Periodic mesoporous organosilica (PMO)
Magnetic mesoporous organosilica drugs (MOD)
Drug delivery systems
Mitoxantrone
Breast cancer treatment
Magnetic nanomedicine
Online Access:https://doi.org/10.1186/s12951-024-02522-4

Internet

https://doi.org/10.1186/s12951-024-02522-4

Similar Items